Changes of Certain Metabolic and Cardiovascular Markers Fructosamine, H-FABP and Lipoprotein (a) in Patients with Hypothyroidism.
Autor: | Kaftan AN; Biochemistry Department, Faculty of Medicine, Kufa University, Najaf, Iraq., Naser FH; Najaf Health Directorate, Najaf, Iraq., Enaya MA; Najaf Health Directorate, Najaf, Iraq. |
---|---|
Jazyk: | angličtina |
Zdroj: | Medical archives (Sarajevo, Bosnia and Herzegovina) [Med Arch] 2021 Feb; Vol. 75 (1), pp. 11-15. |
DOI: | 10.5455/medarh.2021.75.11-15 |
Abstrakt: | Background: Disorders of thyroid gland are common in general population, and it's the most common affecting the endocrine system after diabetes mellitus. Thyroid function regulates a wide range of metabolic parameters, as well as affects some cardiovascular disease risk factors. Fructosamine is produced by a reaction between albumin (protein) and glucose; it is used to monitor patients with diabetes for short-term glycemic changes. H-FABP is present in the cytoplasm of cardiac myocytes, and delivers fatty acids into these cells. It has been shown to increase in myocardial injury. Lipoprotein LP(a) is consist of a special apolipoprotein called apoprotein (a), and it's recognized as a cardiovascular disease independent risk factor. Objective: To study whether certain metabolic and cardiovascular markers (fructosamine, H-FABP and lipoprotein (a) are changed in hypothyroid patients. Methods: The current study included 280 overt hypothyroid, 272 with subclinical hypothyroidism compared with 270 healthy individuals of matched age and gender. For all subjects serum (TSH, T4, T3, FBS, HbA1c, fructosamine, triglycerides, cholesterol, lipoprotein (a), and Heart-type Fatty Acid-Binding Protein (H-FABP)) was measured. Results: Serum fructosamine level significantly elevated (p value <0.05) in patient with hypothyroidism when compared with control group, and no significant change between subclinical and control groups. There is no significant change in serum H-FABP between study subjects. There is significant increase in lipoprotein (a) in patient with hypothyroidism and those with subclinical group when compared with control group. Conclusion: Serum fructosamine and level is significantly changed in patients with overt hypothyroidism when compared with euthyroid subjects. Also, we conclude that hypothyroidism increase risk of cardiovascular diseases by changing non-traditional marker such as lipoprotein (a), and no effect on H-FABP concentration. Competing Interests: Author announces that he has no conflict of interest. (© 2021 Ahmed Naseer Kaftan, Farah H. Naser, Muslim A. Enaya.) |
Databáze: | MEDLINE |
Externí odkaz: |